Cancer Healing Without Treatment? New Antibody 'GT103' Shows Promise After 25 Years Research

• Dr. Edward Patz of Duke University researched for 25 years why some cancer patients survive without specific treatment.
• He discovered a special antibody, 'GT103', in the blood serum of patients whose cancer did not progress or returned.
• Lung cancer patients with natural 'GT103' antibodies showed better outcomes; Dr. Patz founded 'Grid Therapeutics' to develop it into a drug.
• Initial trials on 31 lung cancer patients showed cancer growth stopped in one-third, and one patient's tumor completely disappeared.
• Scientists are now testing 'GT103' with immunotherapy drug 'Keytruda' to enhance its effectiveness, aiming to activate the immune system further.

Why It Matters: A new antibody, 'GT103', discovered after 25 years, offers hope for cancer treatment by boosting natural immunity.